Keiser O, Tweya H, Boulle AM, Braitstein P, Schechter M, et al.
2009-09-10 • AIDS
2009-09-10 • AIDS
BACKGROUND In high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring ...
Nachega JB, Adetokunboh O, Uthman OA, Knowlton AW, Altice FL, et al.
2016-07-30 • Current HIV/AIDS Reports
2016-07-30 • Current HIV/AIDS Reports
Little is known about the effect of community versus health facility-based interventions to improve and sustain antiretroviral therapy (ART) adherence, virologic suppression, and retenti...
Spaar A, Graber C, Dabis F, Coutsoudis A, Bachmann L, et al.
2010-06-01 • AIDS Care
2010-06-01 • AIDS Care
Expanded access to antiretroviral therapy (ART) offers opportunities to strengthen HIV prevention in resource-limited settings. We invited 27 ART programmes from urban settings in Africa...
Calmy A, Balestre E, Bonnet F, Boulle AM, Sprinz E, et al.
2012-12-01 • BMC Infectious Diseases
2012-12-01 • BMC Infectious Diseases
Changes in CD4 cell counts are poorly documented in individuals with low or moderate-level viremia while on antiretroviral treatment (ART) in resource-limited settings. We assessed the i...
Tassie JM, Malateste K, Pujades-Rodriguez M, Poulet E, Bennett DE, et al.
2010-11-10 • PLOS One
2010-11-10 • PLOS One
BACKGROUND: Retention of patients on antiretroviral therapy (ART) over time is a proxy for quality of care and an outcome indicator to monitor ART programs. Using existing databases (Ant...
